found in ovarian cancer that MUC16 binding with a specific CD16(+) CD56(dim) NK cell subset induces their transition from an active to a passive or suppressed state, further aiding immune evasion in ovarian cancer (80). This evidence concerns the gene NCAM1 and ovarian carcinoma.